title: A posttranslational modification of beta-actin contributes to the slow dissociation of the spectrin-protein 4.1-actin complex of irreversibly sickled cells.
abstract: Irreversibly sickled cells (ISCs) remain sickled even under conditions where they are well oxygenated and hemoglobin is depolymerized. In our studies we demonstrate that triton extracted ISC core skeletons containing only spectrin, protein 4.1, and actin also retain their sickled shape; while reversibly sickled cell (RSC) skeletons remodel to a round or biconcave shape. We also demonstrate that these triton extracted ISC core skeletons dissociate more slowly upon incubation at 37 degrees C than do RSC or control (AA) core skeletons. This observation may supply the basis for the inability of the ISC core skeleton to remodel its shape. Using an in vitro ternary complex dissociation assay, we demonstrate that a modification in beta-actin is the major determinant of the slow dissociation of the spectrin-protein 4.1-actin complex isolated from the ISC core skeleton. We demonstrate that the difference between ISC and control beta-actin is the inaccessibility of two cysteine residues in ISC beta-actin to labeling by thiol reactive reagents; due to the formation of a disulfide bridge between cysteine284 and cysteine373 in ISC beta-actin, or alternatively another modification of cysteine284 and cysteine373 which is reversible with DTT and adds less than 100 D to the molecular weight of beta-actin.
authors.affiliation: Department of Structural and Cellular Biology, University of South Alabama College of Medicine, Mobile 36688.
authors.forename: A
authors.initials: A
authors.lastname: Shartava
authors.forename: C A
authors.initials: CA
authors.lastname: Monteiro
authors.forename: F A
authors.initials: FA
authors.lastname: Bencsath
authors.forename: K
authors.initials: K
authors.lastname: Schneider
authors.forename: B T
authors.initials: BT
authors.lastname: Chait
authors.forename: R
authors.initials: R
authors.lastname: Gussio
authors.forename: L A
authors.initials: LA
authors.lastname: Casoria-Scott
authors.forename: A K
authors.initials: AK
authors.lastname: Shah
authors.forename: C A
authors.initials: CA
authors.lastname: Heuerman
authors.forename: S R
authors.initials: SR
authors.lastname: Goodman
mesh_terms: D000199:Actins / Q000737:chemistry / Q000378:metabolism*; D000595:Amino Acid Sequence; D000755:Anemia, Sickle Cell / Q000378:metabolism* / Q000473:pathology; D003198:Computer Simulation; D003598:Cytoskeletal Proteins; D004910:Erythrocyte Membrane / Q000378:metabolism; D004913:Erythrocytes, Abnormal / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D046911:Macromolecular Substances; D013058:Mass Spectrometry; D008565:Membrane Proteins / Q000378:metabolism; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009479:Neuropeptides; D011485:Protein Binding; D011499:Protein Processing, Post-Translational; D017421:Sequence Analysis; D013049:Spectrin / Q000378:metabolism
chemical_list: D000199:Actins; D003598:Cytoskeletal Proteins; D046911:Macromolecular Substances; D008565:Membrane Proteins; D009479:Neuropeptides; C028841:erythrocyte membrane band 4.1 protein; C120557:erythrocyte membrane protein band 4.1-like 1; D013049:Spectrin